scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences

Stock Information for scPharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About scPharmaceuticals Inc.

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences
scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.